Nantahala Capital Management, LLC Uni Qure N.V. Call Options Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
Call Options
21 transactions
Others Institutions Holding QURE
# of Institutions
178Shares Held
51MCall Options Held
2.26MPut Options Held
462K-
Vestal Point Capital, LP New York, NY4.79MShares$68.5 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$61 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$57 Million3.32% of portfolio
-
Abrdn PLC2.75MShares$39.3 Million0.07% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$31.1 Million0.37% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $668M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...